What is Zevra Therapeutics, Inc.'s interest expense?

Zevra Therapeutics, Inc. (ZVRA) reported interest expense of $1.71M in Q1 2026.

How has Zevra Therapeutics, Inc.'s interest expense changed year-over-year?

Zevra Therapeutics, Inc.'s interest expense decreased by 13.1% year-over-year, from $1.97M to $1.71M.

What is the long-term trend for Zevra Therapeutics, Inc.'s interest expense?

Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s interest expense has grown at a 143.7% compound annual growth rate (CAGR), from $226K to $7.98M.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Zevra Therapeutics, Inc. ZVRA Interest Expense

Interest Expense at other companies

BioMarin PharmaceuticalsBMRN

$14.96M+422%

XER

Xeris Biopharma Holdings, Inc.XERS

$6.88M-5.8%

Eton Pharmaceuticals, Inc.ETON

-$840K+18.3%

Theravance BiopharmaTBPH

$582K-9.5%

ANI PharmaceuticalsANIP

-$3.77M+31.3%

Arrowhead ResearchARWR

$23.85M+10.2%

Segments

By segment

See full

Reportable Segment$1.71M-13.1%

Other financials

Income statement

See full

Revenue$36.2M+77.5%

Gross profit$34.3M+80.1%

Operating income$52.1M+1,073%

Net income$37.9M+1,323%

EPS (diluted)$0.60+1,100%

Balance sheet

See full

Cash & equivalents$95.6M+156%

Total debt$1.1M-98.1%

Total equity$205.8M+402%

Total assets$278.6M+61.3%

Cash flow

See full

Operating cash flow$6.1M+175%

CapEx$35.0K-64.6%

Free cash flow$6.1M+173%

Valuation

See full

Market cap$773.23M+56.4%

Enterprise value$678.78M+30.8%

P/E6.2×—

P/S6.3×-5.9×

Profitability

See full

Gross margin86.1%+7.2pp

Operating margin-103.9%-43.0pp

Net margin101.6%+60.1pp

FCF margin-75%-30.5pp

Returns & leverage

See full

Return on equity100.7%+60.3pp

Debt / equity0×-1.5×

Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s interest expense?: Zevra Therapeutics, Inc. (ZVRA) reported interest expense of $1.71M in Q1 2026.
How has Zevra Therapeutics, Inc.'s interest expense changed year-over-year?: Zevra Therapeutics, Inc.'s interest expense decreased by 13.1% year-over-year, from $1.97M to $1.71M.
What is the long-term trend for Zevra Therapeutics, Inc.'s interest expense?: Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s interest expense has grown at a 143.7% compound annual growth rate (CAGR), from $226K to $7.98M.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.